Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2B | P41595 | 15/20 | 0.64 |
| ▸ | HTR3A | P46098 | 1/20 | 0.64 |
| ▸ | HTR2C | P28335 | 4/20 | 0.60 |
| ▸ | AR | P10275 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.54 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.54 |
| ▸ | RAF1 | P04049 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12324852 | 0.83 | HTR2B (0.64) | HTR2BHTR3AHTR2CARMEN1 | |
| SCHEMBL5421595 | 0.80 | RXRA (0.61) | ARMEN1CYP3A4MAPTKMT2A | |
| SCHEMBL17718333 | 0.80 | HPGD (0.46) | HTR2BHTR3AHTR2CMEN1KMT2A | |
| SCHEMBL13718223 | 0.80 | AR (0.54) | HTR2BHTR3AHTR2CAR | |
| SCHEMBL16972802 | 0.80 | HTR2B (0.76) | HTR2BHTR3AHTR2CARMEN1 | |
| SCHEMBL16972779 | 0.78 | HTR2B (0.74) | HTR2BHTR3AHTR2CARMEN1 | |
| SCHEMBL16972760 | 0.78 | HTR2B (1.00) | HTR2BHTR3AHTR2C | |
| SCHEMBL24248100 | 0.78 | POLH (0.56) | HTR2BHTR3AHTR2CARMEN1 | |
| SCHEMBL2268224 | 0.77 | SLC22A12 (0.47) | HTR2BHTR3AHTR2CMAPK1 | |
| SCHEMBL31670262 | 0.77 | MAPT (0.64) | HTR2BHTR3AHTR2CARMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067635-A1 | CROMOLYN DERIVATIVES AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION | 2024-02-29 | — | — | US | disclosed |
| US-11801316-B2 | Cromolyn derivatives and related methods of imaging and treatment | THE GENERAL HOSPITAL CORPORATION (US) | 2023-10-31 | — | — | US | disclosed |
| US-11666669-B2 | Cromolyn derivatives and related methods of imaging and treatment | THE GENERAL HOSPITAL CORPORATION (US) | 2023-06-06 | — | — | US | disclosed |
| US-20180193491-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | THE GENERAL HOSPITAL CORPORATION | 2018-07-12 | — | — | US | disclosed |
| US-20180193492-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | THE GENERAL HOSPITAL CORPORATION | 2018-07-12 | — | — | US | disclosed |
| US-20180169277-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | THE GENERAL HOSPITAL CORPORATION | 2018-06-21 | — | — | US | disclosed |
| US-9925282-B2 | Cromolyn derivatives and related methods of imaging and treatment | THE GENERAL HOSPITAL CORPORATION (US) | 2018-03-27 | — | — | US | disclosed |
| US-20160263257-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | THE GENERAL HOSPITAL CORPORATION | 2016-09-15 | — | — | US | disclosed |
| US-9394288-B2 | Compositions and methods for the treatment of asthma and allergy | CELLIX BIO PRIVATE LIMITED (IN) | 2016-07-19 | — | — | US | disclosed |
| US-20150126593-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ASTHMA AND ALLERGY | CELLIX BIO PRIVATE LIMITED (IN) | 2015-05-07 | — | — | US | disclosed |
| US-20140140927-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | THE GENERAL HOSPITAL CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20120058049-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | THE GENERAL HOSPITAL CORPORATION | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11801316-B2 | Cromolyn derivatives and related methods of imaging and treatment | PSEN1, PSEN2, CROCC | HTR2B 1832/4885HTR3A 700/4885HTR2C 2504/4885 |
| US-20150126593-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ASTHMA AND ALLERGY | LTA4H, LTC4S, ALOX5 | HTR2B 1353/4885HTR3A 677/4885HTR2C 1221/4885 |
| US-20240067635-A1 | CROMOLYN DERIVATIVES AND USES THEREOF | PRNP, HTT, CLN6 | HTR2B 1850/4885HTR3A 793/4885HTR2C 3577/4885 |
| US-20180193491-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | PSEN1, PSEN2, CROCC | HTR2B 1832/4885HTR3A 700/4885HTR2C 2504/4885 |
| US-20140140927-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | PSEN1, PSEN2, CROCC | HTR2B 1724/4885HTR3A 736/4885HTR2C 2539/4885 |
| US-20160263257-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | PSEN1, CROCC, PSEN2 | HTR2B 1831/4885HTR3A 757/4885HTR2C 2547/4885 |
| US-20180193492-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | PSEN1, PSEN2, CROCC | HTR2B 2108/4885HTR3A 797/4885HTR2C 2655/4885 |
| US-20120058049-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | CLN6, CA6, GALNT6 | HTR2B 2326/4885HTR3A 1365/4885HTR2C 3160/4885 |
| US-11666669-B2 | Cromolyn derivatives and related methods of imaging and treatment | PSEN1, PSEN2, CROCC | HTR2B 1724/4885HTR3A 736/4885HTR2C 2539/4885 |
| US-20180169277-A1 | CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT | PSEN1, PSEN2, CROCC | HTR2B 1832/4885HTR3A 700/4885HTR2C 2504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.